Chondrogenic potential of human dermal fibroblasts in a contractile, soft, self-assembling, peptide hydrogel

The present paper describes a simple approach to obtain three‐dimensional (3D) cartilage constructs using human normal dermal fibroblasts (hNDFs) cultured in a self‐assembling peptide nanofibre scaffold. During the first days of culture, the 3D constructs underwent morphological changes consisting o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of tissue engineering and regenerative medicine 2016-02, Vol.10 (2), p.E54-E62
Hauptverfasser: Bussmann, Bianca M., Reiche, Sven, Marí-Buyé, Núria, Castells-Sala, Cristina, Meisel, Hans Jörg, Semino, Carlos E.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present paper describes a simple approach to obtain three‐dimensional (3D) cartilage constructs using human normal dermal fibroblasts (hNDFs) cultured in a self‐assembling peptide nanofibre scaffold. During the first days of culture, the 3D constructs underwent morphological changes consisting of a substantial contraction process that ended in a small compact structure. During this process the system became sensitive to induction with standard chondrogenic medium, evidenced by the expression of specific markers of mature cartilage. First, it was detected that the samples become highly stained with toluidine blue dye over time (40–50 days), indicating that the system produced significantly high amounts of glycosaminoglycans. By quantitative PCR, it was confirmed that the system significantly upregulated the expression of the proteoglycan aggrecan, a good indicator of cartilage commitment. Moreover, collagen type II was upregulated at protein level, confirming that the system differentiated to a chondrocyte‐like construct. Additionally, during the first days of culture in control medium analysed hNDFs proliferation capacity in this 3D system was analysed. This platform could be used in the future to obtain an autologous source of cells from a simple patient skin biopsy, which could be easily translated into a low‐cost and effective regenerative therapy. Copyright © 2013 John Wiley & Sons, Ltd.
ISSN:1932-6254
1932-7005
DOI:10.1002/term.1766